Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with (64)Cu Using NOTA and NODAGA

Imaging using affibody molecules enables discrimination between breast cancer metastases with high and low expression of HER2, making appropriate therapy selection possible. This study aimed to evaluate if the longer half-life of (64)Cu (T(1/2) = 12.7 h) would make (64)Cu a superior nuclide compared...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contrast Media Mol Imaging
Main Authors: Tolmachev, Vladimir, Yim, Cheng-Bin, Rajander, Johan, Perols, Anna, Karlström, Amelie Eriksson, Haaparanta-Solin, Merja, Grönroos, Tove J., Solin, Olof, Orlova, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612711/
https://ncbi.nlm.nih.gov/pubmed/29097939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8565802
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados